Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download personalised medicines - University of Warwick
Document related concepts
Transcript
AC21: 3rd Biennial International Research Festival 4th-7th July 2006 : www.warwick.ac.uk/go/ac21 PERSONALISED MEDICINES SYMPOSIUM http://go.warwick.ac.uk/persmed Wed 5th July 2006 From Genes to Patients: New Perspectives on Personalised Medicines 3rd AC21 Research Festival Medical Teaching Centre, Gibbet Hill Campus, University of Warwick, CV4 7AL, UK REGISTRATION FOR THIS SYMPOSIUM IS NOW OPEN Registration form available from: http://go.warwick.ac.uk/persmed-reginfo DEADLINE FOR ABSTRACT SUBMISSION IS: 26TH JUNE 2006 Abstract Information and guidelines available from: http://go.warwick.ac.uk/persmed-abs KEY TOPICS TO BE COVERED WILL INCLUDE: Genetic targets: CYP enzymes, drug transporters; receptors, cell signalling Genetic methods: genotyping; gene mapping; SNP vs. CNP studies Proteomic approaches to drug discovery Clinical cohort phenotyping and follow up Pharmacovigilance platforms: expert systems and cross-cultural issues Bio-informatics Ethical considerations Health economics of implementing personalised gene testing Intellectual property & patents Patients’ & users’ perspectives Role of regulatory authorities Role of biotechnology industry Role of pharmaceutical industry Role of Small to Medium-sized Enterprises [SMEs] ASSOCIATED INTERNATIONAL RESEARCH FESTIVAL AC21 3rd Biennial International Forum, July 4-6, 2006: See http://go.warwick.ac.uk/research_fest for further information on Symposia on Health Wealth & Nutrition, Nanotechnology, Maths and Media, Sustainable Manufacturing, Global HE Research, Corporate Responsibility. SYMPOSIUM CO-ORDINATORS Miss Carly Hayman +44 (0)24 7696 8649 Mrs Deirdre Prinsloo +44 (0)24 7653 5004 [email protected] SYMPOSIUM CHAIR Professor Donald Singer [email protected] AC21: 3rd Biennial International Research Festival 4th-7th July 2006 : www.warwick.ac.uk/go/ac21 SYMPOSIUM OUTLINE A major opportunity to improve treatment of patients arises from the fact that treatment response can be influenced by individual differences in tissue regulation and drug effectiveness. Differences in treatment response may for example arise from genetic and resulting proteomic differences in drug transporters, receptors and in pathways for drug action. Occurrence of adverse drug reactions (ADRs) can also be associated with genetic differences linked to poor drug metabolism. Pharmacogenetic and pharmacoproteomic profiling thus carries the potential to improve early selection of effective drug treatments, reduce both incidence of ADRs and pressures on medical services. The aim of the symposium is to consider ways in which recent developments in genomics and in proteomics can applied to effective personalised medicine profiling in clinical practice and to consider issues important in implementing into practice the necessary health technology innovations. SPEAKERS AND CHAIRS Professor Vilhjalmur Arnason, Chair of the Centre for Ethics, University of Iceland, Reykjavik Dr Christopher Bridle, Health Psychology, Warwick Professor Ruth Chadwick, Director, ESRC Centre for Economic and Social Aspects of Genomics, Lancaster Dr Kevin Cheeseman, Discovery Medicine & Epidemiology, AstraZeneca R&D Professor Gordon Duff, Chair, Committee on Human Medicines Professor Jan Dumanski, Molecular Oncology, Rudbeck Laboratory, Uppsala University Professor Ralph Edwards, WHO Collaborating Centre for International Drug Monitoring, Uppsala Dr David Elsy PhD, Withers & Rogers LLP Dr Robin Ferner, Director of the West Midlands Centre for Adverse Drug Reaction Reporting Dimitris Grammatopoulos, Director, Molecular Diagnostics Laboratory, UHCW Maj Hulten, Professor of Medical Genetics, University of Warwick Professor Magnus Ingelman-Sundberg, Molecular Toxicology, Institute of Environmental Medicine. Karolinska Institute, Stockholm Christopher McCabe, Professor of Health Economics, Warwick Medical School Dr Duncan McHale, Pharmacogenetics Division, Pfizer Professor Louis Niessen, Institute for Medical Technology Assessment, Erasmus University Dr Sandhosh Padmanabhan, BHF Glasgow Cardiovascular Research Centre Donald Singer, Professor of Clinical Pharmacology & Therapeutics, Warwick Medical School Margaret Thorogood, Professor of Epidemiology, Warwick Medical School SYMPOSIUM CO-ORDINATORS Miss Carly Hayman +44 (0)24 7696 8649 Mrs Deirdre Prinsloo +44 (0)24 7653 5004 [email protected] SYMPOSIUM CHAIR Professor Donald Singer [email protected] AC21: 3rd Biennial International Research Festival 4th-7th July 2006 : www.warwick.ac.uk/go/ac21 LOCAL ORGANISING COMMITTEE INTERNATIONAL SCIENTIFIC COMMITTEE Professor Vilhjalmur Arnason, Ethics, Reykjavik Professor Wendy Currie, Business School Professor Giuseppe Bianchi, Cardiovascular Genetics, Milan Professor Andrew Easton, Infection & Immunity Dr Dimitris Grammatopoulos, Molecular Professor Nicholas Carter, Genetics, London Professor Ruth Chadwick, Ethics, Lancaster UK Diagnostics Professor Jan Dumanski, Genetics, Uppsala Pam Magee, Chief Pharmacist Professor John Hearn, Stem Cell Biology, Sydney Prof Christopher McCabe, Health Economics Professor Maj Hulten, Genetics, Warwick Dr Daniel Mitchell, Pharmacogenomics Professor Magnus Ingelman-Sundberg, Drug Metabolism Dr Teresa Pawlikowska, Primary Care Genetics, Stockholm Prof Donald Singer, Clinical Pharmacology & Therapeutics Professor A A Kroon, Clinical Research, Maastricht Professor Louis Niessen, Health Economics, Rotterdam Prof Margaret Thorogood, Epidemiology Andrew Shindler, Intellectual Property, London Dr Junlong Zhang, Molecular Endocrinology Professor Jan Staessen, Clinical Epidemiology, Leuven WHO SHOULD ATTEND? THIS SYMPOSIUM WILL BE OF INTEREST TO: Biotechnology industries Clinicians Ethicists Experts in Intellectual Property & Patents Health economists Health media Pharmaceutical professionals Pharmacists and other interested health professionals Policy makers Regulatory Authorities Scientists interested in genetics, genomics, proteomics, glycobiology and new therapeutic targets Statisticians, including experts in risk analysis SYMPOSIUM CO-ORDINATORS Miss Carly Hayman +44 (0)24 7696 8649 Mrs Deirdre Prinsloo +44 (0)24 7653 5004 [email protected] SYMPOSIUM CHAIR Professor Donald Singer [email protected] AC21: 3rd Biennial International Research Festival 4th-7th July 2006 : www.warwick.ac.uk/go/ac21 Personalised Medicines Registration Information Please take a moment to review the following information to avoid delays in your registration processing. Registration Fees The deadline for receipt of advance registration is 5th June 2006. Classification On or before 5th June 2006 After 5th June 2006 Standard £80 £90 Early Career £40 £50 Abstract Presenter £0 £0 Early Career: Provide proof of status with a current license or certificate, student ID or a letter written on official letterhead and signed by a mentor, department head or department supervisor. Media Registrants: Reporters, writers, producers or editors with credentials from a newspaper, magazine, online news service, radio or TV network or station, wire service and syndicate may register to attend the Personalised Medicines Symposium. Payment: Full payment must be received with your registration form. Make cheques payable to University of Warwick or charge your registration to American Express, VISA or MasterCard. Registrations without complete payment will not be processed. Wire transfers are not accepted Method of Registration/Payment: Please choose only one of the following methods to register for the Personalised Medicines Symposium: By Fax Remember to include payment information and fax the completed registration form 24 hours a day the Personalised Medicines Office at +44(0)24 7696 8653. By Mail Send your completed registration form with complete payment to: Personalised Medicines Office Clinical Sciences Research Institute Warwick Medical School CSB, University Hospital – Walsgrave Clifford Bridge Road Coventry, CV2 2DX, UK SYMPOSIUM CO-ORDINATORS Miss Carly Hayman +44 (0)24 7696 8649 Mrs Deirdre Prinsloo +44 (0)24 7653 5004 [email protected] SYMPOSIUM CHAIR Professor Donald Singer [email protected] AC21: 3rd Biennial International Research Festival 4th-7th July 2006 : www.warwick.ac.uk/go/ac21 Confirmation: All registrants will receive receipt of registration via e-mail. Badges: Attendees registering in advance will find their badge and conference materials at the Personalised Medicines registration desk at the Medical Teaching Centre, University of Warwick Refunds: A refund will be made if written notice of cancellation is received by 5th May 2006; a £25 cancellation/processing fee will be charged. No refunds will be made after 15th May 2006. Please note: The organisers shall not be liable for cancellation of the Personalised Medicines Symposium caused by labour strikes, civil disorders, fires, weather conditions, or other acts of God or for any damages or losses resulting from such cancellation. Questions? If you have questions regarding registration: e-Mail the Personalised Medicines Office Wed 5th July 2006 From Genes to Patients: New Perspectives on Personalised Medicines 3rd AC21 Research Festival SYMPOSIUM CO-ORDINATORS Miss Carly Hayman +44 (0)24 7696 8649 Mrs Deirdre Prinsloo +44 (0)24 7653 5004 [email protected] SYMPOSIUM CHAIR Professor Donald Singer [email protected]
